Jenscare Scientific Co Ltd

Jenscare Scientific Co Ltd operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the Peoples Republic of China Among its pipeline the company features LuXValve an investigational transcatheter tricuspid valve replacement TTVR system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks Additionally KenValve represents another key product candidate a transcatheter aortic valve replacement TAVR aimed at addressing severe aortic regurgitation often cooccurring with aortic stenosis The applications of Jenscares portfolio extend to a range of structural cardiac maladies including disorders of the tricuspid aortic and mitral valves as well as heart failure Founded in 2011 the company maintains its principal place of business in Ningbo Peoples Republic of China